HELZ is a RNA-DNA helicase that resolves R loops to facilitate homologous recombination repair

This study identifies HELZ as a unique RNA-DNA helicase that resolves R loops by unwinding RNA-DNA hybrids with 5' ssRNA overhangs, thereby facilitating BRCA1 recruitment and homologous recombination repair to maintain genome stability and confer resistance to DNA-damaging agents.

The Gist

The Big Picture: A Cellular Construction Site

Imagine your body's cells are like massive, bustling construction sites. The blueprints for building everything in your body are written in DNA. Sometimes, these blueprints get damaged (a "Double-Strand Break" or DSB), which is like a critical page being ripped out of the instruction manual. If this isn't fixed perfectly, the building (your cell) could collapse, leading to diseases like cancer.

To fix these breaks, the cell has a repair crew. The most skilled, high-precision crew is called Homologous Recombination (HR). They use a backup copy of the blueprint to fix the tear perfectly.

The Problem: The "Tangled Yarn" (R-loops)

Sometimes, while the cell is trying to read the DNA to make copies (transcription), a piece of the new copy (RNA) accidentally sticks back onto the original DNA. This creates a messy knot called an R-loop.

Think of an R-loop like a piece of yarn that has gotten tangled around a zipper.

• If you try to fix the zipper (repair the DNA break) while the yarn is still stuck, the repair crew gets confused.
• They can't get a good grip on the zipper teeth.
• The repair fails, or worse, they make a mistake that causes the whole machine to jam.

For a long time, scientists knew these "tangled yarns" were bad for DNA repair, but they didn't know exactly who was responsible for untangling them.

The Hero: HELZ (The "Yarn Unraveler")

This paper introduces a new hero protein called HELZ. The researchers discovered that HELZ is a specialized helicase—a molecular machine that acts like a pair of smart scissors and a comb.

Here is what HELZ does, step-by-step:

1. It Finds the Mess: When a DNA break happens, HELZ rushes to the scene. It specifically looks for those "tangled yarns" (R-loops) that are blocking the repair site.
2. It Unravels the Knot: HELZ has a special skill. It grabs the RNA part of the tangle and pulls it away from the DNA. It's like a master mechanic who knows exactly how to unhook that specific piece of yarn without breaking the zipper.
3. It Clears the Path: Once the yarn is gone, the DNA is smooth and accessible again.

The Connection: HELZ and the "Team Leader" (BRCA1)

You might have heard of BRCA1. It's a famous protein (often associated with breast cancer risk) that acts as the Team Leader for the DNA repair crew. BRCA1 directs the workers to the break and tells them how to fix it.

The paper found a crucial link:

• Without HELZ: The "tangled yarns" (R-loops) pile up. BRCA1 tries to get to the break, but the yarn is in the way. BRCA1 gets stuck, the repair crew can't start, and the DNA break remains broken.
• With HELZ: HELZ clears the yarn. The path is clear. BRCA1 can walk right up to the break, take charge, and the repair crew gets to work fixing the DNA perfectly.

Why Does This Matter? (The Cancer Connection)

The researchers tested this in cancer cells. They found that if you remove HELZ (take away the "Yarn Unraveler"):

• The cancer cells become very weak when attacked by drugs that break DNA (like chemotherapy or radiation).
• Why? Because without HELZ to clear the tangles, the cancer cells can't repair the damage caused by the drugs. They die.
• However, if the cancer cells have HELZ, they can untangle the mess, fix the DNA, and survive the treatment.

The Takeaway:
HELZ is a vital guardian of our genome. It keeps the DNA repair sites clear of "tangled yarns" so the repair team (led by BRCA1) can do its job. If we can understand how to stop HELZ from working in cancer cells, we might be able to make chemotherapy drugs much more effective, essentially trapping the cancer cells in a mess they can't clean up.

Summary in One Sentence

HELZ is a molecular "clean-up crew" that untangles sticky RNA knots (R-loops) from broken DNA, clearing the way for the repair team (BRCA1) to fix the damage and keep our cells healthy.

Technical Summary

1. Problem Statement

• R-Loop Homeostasis: R-loops (three-stranded structures consisting of an RNA-DNA hybrid and a displaced single-stranded DNA) are essential for physiological processes but can cause genomic instability if they accumulate excessively.
• DNA Double-Strand Break (DSB) Repair: DSBs are highly cytotoxic lesions repaired primarily by Homologous Recombination (HR) or Non-Homologous End Joining (NHEJ). While R-loops are known to exist at DSB sites, their precise role in repair is context-dependent; they can either promote or impair repair.
• The Gap: The mechanisms by which R-loops are resolved specifically to facilitate HR repair are poorly understood. Furthermore, the function of the protein HELZ (Helicase with Zinc Finger), a member of the SF1 RNA helicase family, had not been characterized in the context of DNA damage response (DDR) or R-loop regulation.

2. Methodology

The authors employed a multi-faceted approach combining high-throughput screening, cell biology, biochemistry, and genomics:

• Synthetic Lethal Screen: A siRNA screen targeting 1,006 nuclear enzymes in H128 small cell lung cancer (SCLC) cells to identify genes governing resistance to etoposide (a DSB-inducing agent).
• Cellular Models: Utilization of various cell lines (U2OS, H128, MDA-MB-231, HeLa, DIvA cells) and reporter systems:
  • DR-GFP and EJ7-GFP reporters to measure HR and NHEJ efficiency.
  • mCherry-LacI-Fok1 and AsiSI-ER systems to induce site-specific DSBs.
• Molecular & Biochemical Assays:
  • Immunofluorescence (IF) & Proximity Ligation Assay (PLA): To visualize protein localization (HELZ, BRCA1, $\gamma$H2AX) and R-loops (using S9.6 antibody).
  • Chromatin Immunoprecipitation (ChIP-qPCR): To assess HELZ binding to specific DSB loci.
  • DRIP-seq (DNA-RNA Immunoprecipitation sequencing): To map genome-wide R-loop accumulation upon HELZ depletion.
  • In Vitro Biochemistry: Recombinant HELZ protein was purified to test binding affinity (EMSA, pull-downs) and unwinding activity (helicase assays) on various RNA-DNA hybrid substrates.
  • Rescue Experiments: Overexpression of wild-type (WT) HELZ, catalytic mutants (K674N), and RNase H1 (to degrade RNA-DNA hybrids) to validate mechanisms.

3. Key Contributions

• Identification of HELZ as a Novel DDR Factor: HELZ was identified as a critical mediator of resistance to DSB-inducing agents (etoposide, IR, PARP inhibitors, and Sacituzumab Govitecan).
• Biochemical Characterization: The study establishes HELZ as a unique RNA-DNA helicase with specific activity toward RNA-DNA hybrids containing 5' ssRNA overhangs.
• Mechanistic Link to HR: The paper defines a direct mechanistic pathway where HELZ resolves toxic R-loops at DSB sites to facilitate BRCA1 recruitment, DNA end resection, and subsequent Homologous Recombination.

4. Key Results

A. HELZ Depletion Causes R-Loop Dependent Hypersensitivity

• Depletion of HELZ sensitized cells to etoposide, ionizing radiation (IR), camptothecin, and the antibody-drug conjugate Sacituzumab Govitecan.
• This hypersensitivity was rescued by the expression of RNase H1 (which degrades RNA in RNA-DNA hybrids), confirming the phenotype is driven by R-loop accumulation.

B. HELZ Localizes to DSBs and Binds R-Loops

• HELZ co-localizes with $\gamma$H2AX at Fok1-induced DSBs and accumulates at AsiSI-induced DSB sites (HR1/HR2 loci).
• HELZ physically interacts with R-loops (S9.6 positive) in a damage-dependent manner.
• Biochemical Specificity: HELZ binds and unwinds RNA-DNA hybrids with 5' ssRNA overhangs but shows no activity on pure DNA-DNA hybrids or hybrids with 3' overhangs. This activity is ATP-dependent (abolished by the K674N Walker A mutation).

C. HELZ Prevents Genome-Wide and Local R-Loop Accumulation

• DRIP-seq Analysis: HELZ depletion led to a global increase in R-loops, with significant enrichment at 3'UTRs and transcription termination sites (TTS).
• At DSBs: HELZ depletion caused a significant increase in R-loop accumulation specifically at DSB sites (visualized by increased S9.6/$\gamma$H2AX PLA foci).

D. HELZ Facilitates HR via BRCA1 Recruitment

• HR Defect: HELZ depletion impaired HR efficiency (DR-GFP assay) and reduced IR-induced RAD51 and RPA70 foci formation.
• Resection Defect: HELZ depletion impaired DNA end resection (measured by BrdU incorporation and pRPA levels).
• BRCA1 Recruitment: HELZ depletion prevented the recruitment of BRCA1 to DSBs. Crucially, this defect was rescued by RNase H1, indicating that R-loop accumulation physically blocks BRCA1 access.
• Interaction: HELZ and BRCA1 form a complex in a damage-regulated manner. This interaction is independent of nucleic acids (resistant to Benzonase/RNase H treatment) but HELZ's function in vivo relies on its helicase activity to clear R-loops for BRCA1 to bind.

5. Significance

• Novel Mechanism of Genome Stability: The study elucidates a critical "clean-up" mechanism where HELZ resolves unscheduled R-loops at DSBs. Without this resolution, R-loops sterically hinder the recruitment of BRCA1, blocking DNA end resection and HR repair.
• Therapeutic Implications:
  • Biomarker Potential: HELZ expression levels could serve as a biomarker for predicting response to DSB-inducing therapies, particularly in Triple-Negative Breast Cancer (TNBC) treated with Sacituzumab Govitecan.
  • Synthetic Lethality: Targeting HELZ helicase activity could sensitize cancer cells to PARP inhibitors and other DNA-damaging agents, offering a new strategy for overcoming drug resistance.
• Distinct Biochemical Profile: HELZ is distinguished from other helicases (like Senataxin or BLM) by its specific preference for RNA-DNA hybrids with 5' overhangs and its exclusive binding to ssRNA, suggesting a specialized role in resolving specific R-loop topologies generated during transcription-replication conflicts or DSB repair.

In summary, this paper defines HELZ as a unique RNA-DNA helicase essential for maintaining genome stability by resolving R-loops at DSBs, thereby enabling BRCA1-mediated homologous recombination repair.